- Global Pharma News & Resources

Plant Stem Cell Market to Build Excessive Revenue at Healthy Growth rate at 9.2 % up to 2027 (Covering COVID-19 impact Analysis)

Coherent Market Insights released a new market study on 2021-2027 Plant Stem Cell Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Report offering you more creative solutions that combine our deep geographic experience, intimate sector knowledge and clear insights into how to create value in your business. The research study provides estimates for 2021-2027 Plant Stem Cell Market Forecast till 2027*.

Request Here For Market Latest Insights:

Market Overview:

Plant stem cells are undifferentiated cells located in the meristems of plants. They serve as the origin of plant vitality and provide a steady supply of precursor cells to form various tissues and organs in plants. These cells are used across diverse applications due to their versatility. Moreover, researchers have begun looking to plants as a source for stem cells, and those plant stem cells have proven to be effective in supporting the skin’s cellular turnover. Plant stem cell benefits to the skin include anti-aging, antioxidant, and anti-inflammatory properties.

In stem cell transplantation, stem cells replace cells damaged by disease or chemotherapy or serve as a way for the donor’s immune system to fight off certain types of cancer, as well as blood-related diseases, such as neuroblastoma, lymphoma, leukemia, and multiple myeloma.

Competitive Landscape:

Major players operating in the global plant stem cell market are Oriflame Holding, Renature Skin Care Inc., Phyto Science SDN BHD, Mibelle Biochemistry, Aidan Products LLC, Natura Therapeutics Inc., and MyChelle Dermaceuticals.

Key Market Drivers:

Growing investments in plant stem cell-based research and supportive regulatory framework across developing countries is expected to boost growth of the plant stem cell market during the forecast period. For instance, in October 2019, Stemcell United Ltd. and China Tobacco Corp. partnered to set up a plant stem cell research center. The new center will produce active ingredients for pharmaceutical and healthcare applications.

Moreover, increasing demand for natural compounds along with the rising demand for anti-aging, skincare, haircare, and other cosmetic products is expected to drive growth of the plant stem cell market. For instance, in August 2021, CellaBeauty launched plant based stem cell skincare line, which include deep rejuvenating serum for a brighter complexion, intensive eye solution for aging eyes, and facial regeneration cream for wrinkles and sagging skin. These products are now available across the United States.

COVID-19 Impact Analysis:

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. As cases of COVID-19 continue to rise around the world, the demand for safe and effective treatment is also increasing. Thus, pharma companies worldwide stepped forward to develop treatments and vaccines. As a result, several clinical trials have been registered using stem cells for COVID‐19 treatment that aims to use different cell sources, dosage, and importantly diverse targeted patient groups. This is expected to aid the growth of the plant stem cell market.

Key Takeaways

  • The plant stem cell market is expected to exhibit a CAGR of XX % during the forecast period due to increasing product launches by market players. Market players are adopting various strategies such as product launches, to gain competitive edge in the market. For instance, in April 2019, Tremotyx launched plant stem cell-based eczema treatment in the United States, after its successful launch in Germany.
  • Among regions, North America and Asia Pacific are expected to witness robust growth in the plant stem cell market due to increasing investments in plant stem cell-based research and supportive regulatory framework. For instance, in February 2020, Global Institute of Stem Cell Therapy and Research (GIOSTAR) announced the inauguration of a new stem cell/cancer research and therapy center in Chandigarh, India. This facility represents the latest milestone in global expansion efforts spearheaded by GIOSTAR in India, Mexico, the United States, and numerous other countries.

Purchase this Report at Discount Of US $2000 Flat OFF –

Reasons to Purchase this Report

• Current and future of global Plant Stem Cell Market outlook in the developed and emerging markets • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period. • Regions/countries that are expected to witness the fastest growth rates during the forecast period • The latest developments, market shares, and strategies that are employed by the major market players

Major Point Answered in Plant Stem Cell Market Research Study are:

  • What will be the progress rate of the Plant Stem Cell Market for the conjecture period, 2021-2027?
  • What are the prominent factors driving the Plant Stem Cell Market across different regions?
  • Who are the major vendors dominating the Plant Stem Cell industry and what are their winning strategies?
  • What will be the market scope for the estimated period?
  • What are the major trends shaping the expansion of the industry in the coming years?
  • What are the challenges faced by the Plant Stem Cell Market?

Request Here Sample Report @

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 23-Sep-2021